Phase I trial of COTI 2 in patients with recurrent head and neck squamous cell cancer.
Phase of Trial: Phase I
Latest Information Update: 22 Jan 2015
At a glance
- Drugs COTI 2 (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions
- 22 Jan 2015 New trial record